Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 49Gynecologic 26Dermatologic 11Head & Neck 7Gastrointestinal 6Lymphoid 3Tumor-Agnostic 2Other hematologic neoplasm 2Genitourinary 2Thoracic 1Sarcoma 1Other solid neoplasm 1

Conditions

Pediatric Patients With Solid Tumors 1

Interventions

Cisplatin 147pembrolizumab 129Carboplatin 126Injections 108Pemetrexed 99Paclitaxel 97Gemcitabine 85Irinotecan 75Cyclophosphamide 72Nivolumab 71Docetaxel 68Bevacizumab 59Oxaliplatin 50Fluorouracil 50Capecitabine 48atezolizumab 46Leucovorin 42Etoposide 42tislelizumab 40toripalimab 36fludarabine 32Drug Therapy 32Ipilimumab 30Topotecan 29durvalumab 28Vincristine 27Specimen Handling 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sentinel Lymph Node Biopsy × Other solid neoplasm × Clear all
NCT02910726 2022-10-05

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Memorial Sloan Kettering Cancer Center

Phase 2/3 Completed
6 enrolled 4 charts
Other solid neoplasm

Pediatric Patients With Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡